BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Dune Medical Devices Ltd. Release: Ludwig-Maximilians University Hospital of Munich (LMU), Germany Begins Use of The MarginProbe System


2/28/2013 10:40:42 AM

BOSTON, Feb. 28, 2013 /PRNewswire/ -- Dune Medical Devices announced today that the MarginProbe System will be used at the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Hospital, in Munich, Germany. The Breast Center treats over 400 primary breast cancer cases annually at its two sites Maistrasse-Innenstadt and Grosshadern.

"We are excited to get started with the MarginProbe System. With currently available techniques, positive margins are a significant problem for patients," said Professor Nadia Harbeck, Head of the Breast Center. "The amount of data supporting the use of the MarginProbe System is significant, and we look forward to offering it to our patients," adds PD Dr. Darius Dian, the Head of Breast Surgery.

"The LMU-University Hospital in Munich is a well-known hospital around the world for the high quality of patient care offered," says Dune's Chief Executive Officer Dan Levangie. "By improving surgeons' ability to detect positive margins during surgery, the MarginProbe System can significantly improve patients' experiences being treated for breast cancer. We are excited to begin our collaboration with this influential center."

About Dune Medical Devices
Dune Medical Devices was founded in 2002 by Dr. Dan Hashimshony to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the real time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications. The MarginProbe System is Dune's first commercial product and is commercially available in Europe and the US.

Dune Medical Devices is a privately held company financed by Apax Partners since 2004. It has offices in the U.S., Israel, Germany and Switzerland. For more information, please visit www.dunemedical.com

Contact:

Michael Graffeo, Director of Marketing, Dune Medical Devices


508-620-2782 / michael.graffeo@dunemedical.com

SOURCE Dune Medical Devices


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->